OPKO Health : Immediate Report | MarketScreener
Pfizer and OPKO's Once-Weekly NGENLATM Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency NEW YORK... | February 15, 2022
Source: marketscreener.com